The Antitubercular Activities of Natural Products with Fused-Nitrogen-Containing Heterocycles
Tuberculosis (TB) is notorious as the leading cause of death worldwide due to a single infectious entity and its causative agent, <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>), has been able to evolve resistance to all existing drugs in the treatment arsenal complicating dis...
Main Authors: | Helena I. Boshoff, Neha Malhotra, Clifton E. Barry, Sangmi Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/17/2/211 |
Similar Items
-
Sequential Dramatic Regrowth of a Lumbar Pedicle Post–Antitubercular Therapy
by: Saurabh Kumar Verma, et al.
Published: (2016-06-01) -
Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds
by: Guilherme Felipe dos Santos Fernandes, et al.
Published: (2017-06-01) -
Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets
by: Sangmi Oh, et al.
Published: (2021-03-01) -
Deciphering the mechanism of action of antitubercular compounds with metabolomics
by: Isin T. Sakallioglu, et al.
Published: (2021-01-01) -
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug
by: Giorgia Mori, et al.
Published: (2020-02-01)